Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAREMI: Allogeneic Human CSCs in AMI
NCT02439398Phase 2Completed
- Sponsor
- Coretherapix
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of AlloCSC-01 in acute myocardial infarction (AMI), sponsored by Coretherapix. Started Jun 2014; status: completed.
02
Drugs
AlloCSC-01
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT02439398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439398.